Puma Biotechnology, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK, INC. | 02/07/2025 | 3.82 M | $11.66 M | -0.09% | 7.80% |
VANGUARD GROUP INC | 02/11/2025 | 3.64 M | $11.11 M | 0.20% | 7.43% |
02/14/2025 | 2.45 M | $12.02 M | 100.00% | 5.00% | |
ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 1.97 M | $6.01 M | 0.16% | 4.02% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 1.89 M | $5.78 M | -34.25% | 3.86% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 1.76 M | $5.35 M | -0.95% | 3.58% |
EVERSEPT PARTNERS, LP | 02/14/2025 | 996,102 | $3.04 M | -22.98% | 2.03% |
AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 948,376 | $2.89 M | 8.44% | 1.94% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 919,435 | $2.80 M | 0.23% | 1.88% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 863,760 | $2.64 M | 24.68% | 1.76% |
KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2025 | 809,375 | $2.47 M | 36.48% | 1.65% |
STATE STREET CORP | 02/14/2025 | 609,942 | $1.86 M | 1.40% | 1.24% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 487,368 | $1.49 M | 32.27% | 0.99% |
GLOBEFLEX CAPITAL L P | 02/10/2025 | 452,606 | $1.38 M | 0.00% | 0.92% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 331,853 | $1.01 M | 19.50% | 0.68% |
NORTHERN TRUST CORP | 02/14/2025 | 325,417 | $992,522 | 2.42% | 0.66% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 314,097 | $957,996 | 2.74% | 0.64% |
SEI INVESTMENTS CO | 02/11/2025 | 311,661 | $950,557 | 8.03% | 0.64% |
LOS ANGELES CAPITAL MANAGEMENT LLC | 02/04/2025 | 285,679 | $871,321 | 16.27% | 0.58% |
MORGAN STANLEY | 02/14/2025 | 270,334 | $824,520 | -3.95% | 0.55% |
D. E. SHAW & CO., INC. | 02/14/2025 | 222,608 | $678,954 | 287.90% | 0.45% |
TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 200,000 | $610,000 | 0.00% | 0.41% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 196,900 | $600,545 | 22.30% | 0.40% |
QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 188,124 | $573,778 | -7.88% | 0.38% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 181,471 | $553,487 | 266.20% | 0.37% |
PROSPERA FINANCIAL SERVICES INC | 02/13/2025 | 177,895 | $542,553 | 5.34% | 0.36% |
FEDERATED HERMES, INC. | 02/13/2025 | 163,641 | $499,105 | 2.16% | 0.33% |
CITADEL ADVISORS LLC | 02/14/2025 | 159,425 | $486,246 | 2,214.20% | 0.33% |
UBS GROUP AG | 02/14/2025 | 155,571 | $474,492 | 474.19% | 0.32% |
JPMORGAN CHASE & CO | 02/12/2025 | 136,897 | $417,535 | 182.30% | 0.28% |
FMR LLC | 02/13/2025 | 131,850 | $402,143 | 11.49% | 0.27% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 117,666 | $358,881 | 0.00% | 0.24% |
O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 02/12/2025 | 112,571 | $343,342 | 99.70% | 0.23% |
GSA CAPITAL PARTNERS LLP | 02/07/2025 | 108,523 | $331,000 | 119.27% | 0.22% |
PRUDENTIAL FINANCIAL INC | 02/11/2025 | 106,285 | $324,169 | 5.77% | 0.22% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 105,200 | $320,860 | 0.77% | 0.21% |
BARCLAYS PLC | 02/13/2025 | 88,407 | $270,000 | 13.31% | 0.18% |
MARSHALL WACE, LLP | 02/13/2025 | 85,580 | $261,019 | 100.00% | 0.17% |
ROYAL BANK OF CANADA | 02/14/2025 | 82,882 | $253,000 | 1,178.06% | 0.17% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 82,339 | $251,134 | 103.06% | 0.17% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 79,101 | $241,258 | 41.45% | 0.16% |
MACKENZIE FINANCIAL CORP | 02/20/2025 | 78,653 | $239,892 | 100.00% | 0.16% |
SQUAREPOINT OPS LLC | 02/14/2025 | 75,929 | $231,583 | -23.49% | 0.15% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 75,103 | $229,064 | 100.00% | 0.15% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 74,301 | $226,618 | 9.75% | 0.15% |
MACQUARIE GROUP LTD | 02/14/2025 | 61,255 | $187,000 | 0.00% | 0.13% |
02/13/2025 | 59,866 | $182,591 | 100.00% | 0.12% | |
XTX TOPCO LTD | 02/13/2025 | 59,674 | $182,006 | 126.18% | 0.12% |
PANAGORA ASSET MANAGEMENT INC | 02/13/2025 | 58,849 | $179,489 | -42.32% | 0.12% |
LSV ASSET MANAGEMENT | 02/13/2025 | 53,400 | $163,000 | 75.66% | 0.11% |
Puma Biotechnology, Inc. institutional Ownership - FAQ's
During the previous two years, 165 institutional investors and hedge funds held shares of Puma Biotechnology, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 3.82 M
VANGUARD GROUP INC: 3.64 M
ACADIAN ASSET MANAGEMENT LLC: 1.97 M
MILLENNIUM MANAGEMENT LLC: 1.89 M
RENAISSANCE TECHNOLOGIES LLC: 1.76 M
Eversept Partners, LP: 996,102
56.56% of Puma Biotechnology, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 35.95 M shares in the last 24 months. This purchase volume represents approximately $104.26 M in transactions.